US Patent Issued to Amgen on May 19 for "IL-10 muteins and fusion proteins thereof" (California Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,598, issued on May 19, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "IL-10 muteins and fusion proteins thereof" was invented by Haili... Read More

US Patent Issued to OBSIDIAN THERAPEUTICS on May 19 for "CA2 compositions and methods for tunable regulation" (Massachusetts Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,599, issued on May 19, was assigned to OBSIDIAN THERAPEUTICS INC. (Cambridge, Mass.). "CA2 compositions and methods for tunable regulation" ... Read More

US Patent Issued to MedImmune on May 19 for "GLP-1 and glucagon dual agonist peptides with improved biological stability" (British Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,600, issued on May 19, was assigned to MedImmune Ltd. (Cambridge, Great Britain). "GLP-1 and glucagon dual agonist peptides with improved bi... Read More

US Patent Issued to ELI LILLY and Co. on May 19 for "Process for preparing a GIP/GLP1 dual agonist" (Indiana Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,601, issued on May 19, was assigned to ELI LILLY AND COMPANY (Indianapolis). "Process for preparing a GIP/GLP1 dual agonist" was invented by... Read More

US Patent Issued to Rutgers, The State University of New Jersey on May 19 for "Methods and compositions for treating diseases and disorders of the nervous system" (New Jersey Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,602, issued on May 19, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.). "Methods and compositions for trea... Read More

US Patent Issued to KITE PHARMA on May 19 for "Chimeric antigen receptor T cell therapy" (California Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,603, issued on May 19, was assigned to KITE PHARMA INC. (Santa Monica, Calif.). "Chimeric antigen receptor T cell therapy" was invented by A... Read More

US Patent Issued to Novartis on May 19 for "Methods of making chimeric antigen receptor-expressing cells" (American, Swiss Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,604, issued on May 19, was assigned to Novartis AG (Basel, Switzerland). "Methods of making chimeric antigen receptor-expressing cells" was ... Read More

US Patent Issued to Ohio State Innovation Foundation on May 19 for "Tissue factor-targeting CAR-NK and CAR-T cell therapy" (Ohio Inventor)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,605, issued on May 19, was assigned to Ohio State Innovation Foundation (Columbus, Ohio). "Tissue factor-targeting CAR-NK and CAR-T cell the... Read More

US Patent Issued to The Regents of the University of California on May 19 for "Peptide deficient-MHC class I/chaperone compositions and methods" (Pennsylvania Inventor)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,606, issued on May 19, was assigned to The Regents of the University of California (Oakland, Calif.). "Peptide deficient-MHC class I/chapero... Read More

US Patent Issued to BioNTech on May 19 for "PRAME TCR receptors and uses thereof" (German Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,607, issued on May 19, was assigned to BioNTech SE (Mainz, Germany). "PRAME TCR receptors and uses thereof" was invented by Manon Weis (Sank... Read More

• ««
• «
• 2729
• 2730
• 2731
• 2732
• 2733
• 2734
• 2735
• 2736
• 2737
• 2738
• »
• »»